MediXall (MDXL) Return on Assets (2019 - 2024)
MediXall's Return on Assets history spans 5 years, with the latest figure at 9.63% for Q3 2024.
- For Q3 2024, Return on Assets rose 70.0% year-over-year to 9.63%; the TTM value through Sep 2024 reached 9.63%, up 70.0%, while the annual FY2023 figure was 8.58%, 173.0% down from the prior year.
- Return on Assets reached 9.63% in Q3 2024 per MDXL's latest filing, up from 13.31% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 2.72% in Q1 2021 to a low of 16.19% in Q1 2024.
- Average Return on Assets over 4 years is 8.12%, with a median of 7.26% recorded in 2022.
- The largest YoY upside for Return on Assets was 70bps in 2024 against a maximum downside of -857bps in 2024.
- A 4-year view of Return on Assets shows it stood at 4.77% in 2021, then crashed by -52bps to 7.26% in 2022, then tumbled by -92bps to 13.9% in 2023, then skyrocketed by 31bps to 9.63% in 2024.
- Per Business Quant, the three most recent readings for MDXL's Return on Assets are 9.63% (Q3 2024), 13.31% (Q2 2024), and 16.19% (Q1 2024).